Arbor Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-168
Closed -$31K 58
2019
Q2
$31K Buy
168
+102
+155% +$18.3K 0.02% 97
2019
Q1
$13K Buy
+66
New +$12.6K 0.01% 126
2017
Q3
Sell
-8,713
Closed -$1.48M 63
2017
Q2
$1.48M Buy
8,713
+133
+2% +$21.6K 1.4% 30
2017
Q1
$1.37M Buy
8,580
+79
+0.9% +$13.1K 1.21% 33
2016
Q4
$1.42K Buy
8,501
+83
+1% +$12.5K 1.11% 33
2016
Q3
$1.36M Hold
8,418
1.16% 32
2016
Q2
$1.47M Buy
8,418
+4,668
+124% +$726K 1.38% 29
2016
Q1
$586K Buy
3,750
+2,431
+184% +$361K 0.61% 39
2015
Q4
$188K Buy
+1,319
New +$207K 0.21% 77

Other funds holding AMGN

Arbor Wealth Management's AMGN Position: Q3 2019 in Review

Arbor Wealth Management sold out of Amgen (AMGN) in Q3 2019, closing a stake of 168 shares — an estimated $31K sold.

Arbor Wealth Management first reported a position in AMGN in Q4 2015 and held it in 9 quarters. The position peaked at $1.48M in Q2 2017. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Arbor Wealth Management reported no remaining Amgen position as of Q3 2019 after selling out during the quarter.
  • Arbor Wealth Management sold 168 Amgen shares in Q3 2019, an estimated $31K.
  • Arbor Wealth Management first reported a position in Amgen in Q4 2015 and held it in 9 quarters.
  • Arbor Wealth Management's Amgen position peaked at $1.48M in Q2 2017.
  • 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Arbor Wealth Management's 13F filing for Q3 2019, filed 6 Nov 2019.